申请人:Kuo Sheng-Chu
公开号:US20090131681A1
公开(公告)日:2009-05-21
A fused pyrazolyl compound having an anti-tumor potency of the following formula is synthesized:
wherein A is
in which n is 0, 1, 2, or 3; Ar
1
is benzene, thiophene or furan; Ar
2
is furyl; and Ar
3
is phenyl; R
1
and R
2
independently are hydrogen, halogen or —(CH
2
)
m
OR
e
; R
3
is hydrogen or alkyl; R
4
is —(CH
2
)
r
-A
1
, wherein r is an integer of 1-5, and A
1
has a formula of —O—C(O)—(CR
c
H)
q
—NR
c′
R
d′
; R
5
and R
6
independently are hydrogen, halogen, or alkyl, or R
5
and R
6
together are —O(CH
2
)
m
O—; R
c
is H, halogen, nitro, cyano, alkyl, or aryl; R
e
is H, alkyl, or aryl; R
c′
and R
d′
independently are H, alkyl, or aryl; m is 0, 1, 2, 3, 4, 5, or 6; and q is 1, 2, 3, 4, 5, or 6; or a salt thereof.
已合成具有以下化学式的具有抗肿瘤活性的融合吡唑基化合物:其中A为,其中n为0、1、2或3;Ar1为苯、噻吩或呋喃;Ar2为呋喃基;Ar3为苯基;R1和R2独立地为氢、卤素或—(CH2)mORe;R3为氢或烷基;R4为—(CH2)r-A1,其中r为1-5的整数,A1具有—O—C(O)—(CRcH)q—NRc′Rd′的化学式;R5和R6独立地为氢、卤素或烷基,或者R5和R6一起为—O(CH2)mO—;Rc为H、卤素、硝基、氰基、烷基或芳基;Re为H、烷基或芳基;Rc′和Rd′独立地为H、烷基或芳基;m为0、1、2、3、4、5或6;q为1、2、3、4、5或6;或其盐。